{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:19:17Z","timestamp":1792844357418,"version":"4.5.0"},"reference-count":132,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:00:00Z","timestamp":1646956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004252","name":"Qatar University","doi-asserted-by":"publisher","award":["QUHI-BRC-20_21-1"],"award-info":[{"award-number":["QUHI-BRC-20_21-1"]}],"id":[{"id":"10.13039\/501100004252","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Recent progress in genomics and bioinformatics technologies have allowed for the emergence of immunogenomics field. This intersection of immunology and genetics has broadened our understanding of how the immune system responds to infection and vaccination. While the immunogenetic basis of the huge clinical variability in response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is currently being extensively studied, the host genetic determinants of SARS-CoV-2 vaccines remain largely unknown. Previous reports evidenced that vaccines may not protect all populations or individuals equally, due to multiple host- and vaccine-specific factors. Several studies on vaccine response to measles, rubella, hepatitis B, smallpox, and influenza highlighted the contribution of genetic mutations or polymorphisms in modulating the innate and adaptive immunity following vaccination. Specifically, genetic variants in genes encoding virus receptors, antigen presentation, cytokine production, or related to immune cells activation and differentiation could influence how an individual responds to vaccination. Although such knowledge could be utilized to generate personalized vaccine strategies to optimize the vaccine response, studies in this filed are still scarce. Here, we briefly summarize the scientific literature related to the immunogenetic determinants of vaccine-induced immunity, highlighting the possible role of host genetics in response to SARS-CoV-2 vaccines as well.<\/jats:p>","DOI":"10.3389\/fmed.2022.802312","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T06:46:16Z","timestamp":1646981176000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Will Host Genetics Affect the Response to SARS-CoV-2 Vaccines? Historical Precedents"],"prefix":"10.3389","volume":"9","author":[{"given":"Maria K.","family":"Smatti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hebah A.","family":"Alkhatib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa A.","family":"Al Thani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi M.","family":"Yassine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,11]]},"reference":[{"key":"B1","unstructured":"COVID-19 Coronavirus Pandemic2022"},{"key":"B2","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.1016\/j.vaccine.2017.07.062","article-title":"Personalized vaccinology: a review","volume":"36","author":"Poland","year":"2018","journal-title":"Vaccine."},{"key":"B3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00439-017-1768-9","article-title":"Genome-wide associations of CD46 and IFI44L genetic variants with neutralizing antibody response to measles vaccine","volume":"136","author":"Haralambieva","year":"2017","journal-title":"Hum Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00251-014-0776-3","article-title":"Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipients","volume":"66","author":"Kennedy","year":"2014","journal-title":"Immunogenetics."},{"key":"B5","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/hep.29876","article-title":"Key HLA-DRB1-DQB1 haplotypes and role of the BTNL2 gene for response to a hepatitis B vaccine","volume":"68","author":"Nishida","year":"2018","journal-title":"Hepatology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"20166","DOI":"10.3390\/ijerph14020166","article-title":"Possible impact of 190G > A CCR2 and \u039432 CCR5 mutations on decrease of the HBV vaccine immunogenicity-a preliminary report","volume":"14","author":"Ganczak","year":"2017","journal-title":"Int J Environ Res Public Health"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1016\/j.vaccine.2012.05.032","article-title":"A genome-wide association study of host genetic determinants of the antibody response to Anthrax Vaccine Adsorbed","volume":"30","author":"Pajewski","year":"2012","journal-title":"Vaccine."},{"key":"B8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1586\/erv.12.134","article-title":"The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches","volume":"12","author":"Haralambieva","year":"2013","journal-title":"Expert Rev Vaccines."},{"key":"B9","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.immuni.2020.05.004","article-title":"Respiratory virus infections: understanding COVID-19","volume":"52","author":"Subbarao","year":"2020","journal-title":"Immunity."},{"key":"B10","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1084\/jem.20200678","article-title":"The many faces of the anti-COVID immune response","volume":"217","author":"Vardhana","year":"2020","journal-title":"J Exp Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu Rev Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"40783","DOI":"10.3390\/vaccines8040783","article-title":"Harnessing cellular immunity for vaccination against respiratory viruses","volume":"8","author":"Lukacs","year":"2020","journal-title":"Vaccines"},{"key":"B13","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.immuni.2007.09.002","article-title":"Antibodies and B cell memory in viral immunity","volume":"27","author":"D\u00f6rner","year":"2007","journal-title":"Immunity"},{"key":"B14","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/ni.2039","article-title":"Immunological mechanisms of vaccination","volume":"12","author":"Pulendran","year":"2011","journal-title":"Nat Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1084\/jem.20051720","article-title":"Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity","volume":"203","author":"Querec","year":"2006","journal-title":"J Exp Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature09737","article-title":"Programming the magnitude and persistence of antibody responses with innate immunity","volume":"470","author":"Kasturi","year":"2011","journal-title":"Nature."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.vaccine.2008.01.017","article-title":"Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results","volume":"26","author":"Dhiman","year":"2008","journal-title":"Vaccine."},{"key":"B18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.addr.2020.06.002","article-title":"Lipid nanoparticles for nucleic acid delivery: current perspectives","volume":"5","author":"Samaridou","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.tibs.2021.03.002","article-title":"COVID-19 vaccines based on adenovirus vectors","volume":"46","author":"Hasanpourghadi","year":"2021","journal-title":"Trends Biochem Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1016\/j.vaccine.2008.06.057","article-title":"Vaccine immunogenetics: bedside to bench to population","volume":"26","author":"Poland","year":"2008","journal-title":"Vaccine."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1016\/S0264-410X(00)00468-0","article-title":"Twin studies of immunogenicity\u2013determining the genetic contribution to vaccine failure","volume":"19","author":"Tan","year":"2001","journal-title":"Vaccine."},{"key":"B23","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0140-6736(02)11083-X","article-title":"Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins","volume":"360","author":"H\u00f6hler","year":"2002","journal-title":"Lancet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/sj.gene.6364051","article-title":"Genetic regulation of immune responses to vaccines in early life","volume":"5","author":"Newport","year":"2004","journal-title":"Genes Immun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1007\/978-981-13-0050-9","article-title":"GWAS identifying HLA-DPB1 gene variants associated with responsiveness to hepatitis B virus vaccination in Koreans: independent association of HLA-DPB1*04:02 possessing rs1042169 G - rs9277355 C - rs9277356 A","volume":"26","author":"Chung","year":"2019","journal-title":"J Viral Hepat."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1093\/hmg\/ddt586","article-title":"A genome-wide association study identifies polymorphisms in the HLA-DR region associated with non-response to hepatitis B vaccination in Chinese Han populations","volume":"23","author":"Pan","year":"2014","journal-title":"Hum Mol Genet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1093\/hmg\/ddr302","article-title":"genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region","volume":"20","author":"Png","year":"2011","journal-title":"Hum Mol Genet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ng.3129","article-title":"Common variants associated with general and MMR vaccine-related febrile seizures","volume":"46","author":"Feenstra","year":"2014","journal-title":"Nat Genet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.ebiom.2019.01.041","article-title":"Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survival","volume":"40","author":"Hallberg","year":"2019","journal-title":"EBioMedicine."},{"key":"B30","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/infdis\/jix538","article-title":"Polymorphisms in the wilms tumor gene are associated with interindividual variations in rubella virus-specific cellular immunity after measles-mumps-rubella II vaccination","volume":"217","author":"Voigt","year":"2018","journal-title":"J Infect Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1016\/j.vaccine.2012.04.055","article-title":"Genome-wide association study of antibody response to smallpox vaccine","volume":"30","author":"Ovsyannikova","year":"2012","journal-title":"Vaccine."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00439-012-1174-2","article-title":"Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients","volume":"131","author":"Kennedy","year":"2012","journal-title":"Hum Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1016\/j.celrep.2019.05.053","article-title":"Common genetic variations associated with the persistence of immunity following childhood immunization","volume":"27","author":"O'Connor","year":"2019","journal-title":"Cell Rep"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1128\/JVI.78.9.4385-4388.2004","article-title":"Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet","volume":"78","author":"Cattaneo","year":"2004","journal-title":"J Virol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"6398","DOI":"10.4049\/jimmunol.1100159","article-title":"Quantitative trait locus analysis, pathway analysis, and consomic mapping show genetic variants of Tnni3k, Fpgt, or H28 control susceptibility to viral myocarditis","volume":"186","author":"Wiltshire","year":"2011","journal-title":"J Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"4665","DOI":"10.1016\/j.febslet.2010.10.045","article-title":"Wilms' tumor protein Wt1 regulates the Interleukin-10 (IL-10) gene","volume":"584","author":"Sciesielski","year":"2010","journal-title":"FEBS Lett."},{"key":"B37","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00251-017-1000-z","article-title":"Host genetic variation and HIV disease: from mapping to mechanism","volume":"69","author":"Naranbhai","year":"2017","journal-title":"Immunogenetics."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1093\/hmg\/ddr301","article-title":"A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population","volume":"20","author":"Mbarek","year":"2011","journal-title":"Hum Mol Genet."},{"key":"B39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40001-021-00516-8","article-title":"Genetic susceptibility of COVID-19: a systematic review of current evidence","volume":"26","author":"SeyedAlinaghi","year":"2021","journal-title":"Eur J Med Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"601886","DOI":"10.3389\/fimmu.2020.601886","article-title":"HLA, immune response, and susceptibility to COVID-19","volume":"11","author":"Tavasolian","year":"2020","journal-title":"Front Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"7354","DOI":"10.4049\/jimmunol.176.12.7354","article-title":"BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation","volume":"176","author":"Nguyen","year":"2006","journal-title":"J Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1586\/14760584.2015.1038249","article-title":"Adversomics: a new paradigm for vaccine safety and design","volume":"14","author":"Whitaker","year":"2015","journal-title":"Expert Rev Vaccines."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1086\/587844","article-title":"Immune response during adverse events after 17D-derived yellow fever vaccination in Europe","volume":"197","author":"Bae","year":"2008","journal-title":"J Infect Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1101\/2021.11.30.21267043","article-title":"Identification of susceptibility loci for adverse events following COVID-19 vaccination in the Japanese population: a web-based genome-wide association study","volume":"2021","author":"Nogawa","year":"2021","journal-title":"medRxiv"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1016\/j.vaccine.2011.02.071","article-title":"Atopy history and the genomics of wheezing after influenza vaccination in children 6-59 months of age","volume":"29","author":"Miller","year":"2011","journal-title":"Vaccine."},{"key":"B46","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1086\/588670","article-title":"Genetic basis for adverse events following smallpox vaccination","volume":"198","author":"Reif","year":"2008","journal-title":"J Infect Dis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1086\/518794","article-title":"The immunogenetics of smallpox vaccination","volume":"196","author":"Stanley","year":"2007","journal-title":"J Infect Dis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1086\/590187","article-title":"Case of yellow fever vaccine\u2013associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes","volume":"198","author":"Pulendran","year":"2008","journal-title":"J Infect Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s10875-019-00653-0","article-title":"Correction to: life-threatening infections due to live-attenuated vaccines: early manifestations of inborn errors of immunity","volume":"39","author":"P\u00f6yh\u00f6nen","year":"2019","journal-title":"J Clin Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1111\/all.14364","article-title":"Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19","volume":"75","author":"Azkur","year":"","journal-title":"Allergy"},{"key":"B51","doi-asserted-by":"publisher","first-page":"30238","DOI":"10.3390\/vaccines9030238","article-title":"Correlates of vaccine-induced protection against SARS-CoV-2","volume":"9","author":"Koch","year":"2021","journal-title":"Vaccines"},{"key":"B52","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41392-021-00611-6","article-title":"Dynamics of neutralizing antibody responses to SARS-CoV-2 in patients with COVID-19: an observational study","volume":"6","author":"Xu","year":"2021","journal-title":"Signal Transduct Target Ther."},{"key":"B53","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41564-020-00824-5","article-title":"Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals","volume":"6","author":"Zhang","year":"2021","journal-title":"Nat Microbiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"Le Bert","year":"2020","journal-title":"Nature."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1056\/NEJMc070348","article-title":"Disappearance of antibodies to SARS-associated coronavirus after recovery","volume":"357","author":"Cao","year":"2007","journal-title":"N Engl J Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.3389\/fimmu.2020.01949","article-title":"Overview of immune response during SARS-CoV-2 infection: lessons from the past","volume":"11","author":"Shah","year":"2020","journal-title":"Front Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1128\/CMR.00048-08","article-title":"HLA and infectious diseases","volume":"22","author":"Blackwell","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e2100087","DOI":"10.1002\/bies.202100087","article-title":"Personalized health and the coronavirus vaccines-do individual genetics matter?","volume":"43","author":"Vald\u00e9s-Fern\u00e1ndez","year":"2021","journal-title":"Bioessays."},{"key":"B59","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.clinimag.2020.05.013","article-title":"Extrapulmonary manifestations of COVID-19: radiologic and clinical overview","volume":"66","author":"Behzad","year":"2020","journal-title":"Clin Imaging."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41436-021-01113-0","article-title":"The intersection of genetics and COVID-19 in 2021: preview of the 2021 Rodney Howell Symposium","volume":"23","author":"Rasmussen","year":"2021","journal-title":"Genet Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3349\/ymj.2016.57.1.15","article-title":"Recent advances in Kawasaki disease","volume":"57","author":"Kim","year":"2016","journal-title":"Yonsei Med J."},{"key":"B62","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00296-020-04749-4","article-title":"Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management","volume":"41","author":"Kabeerdoss","year":"2021","journal-title":"Rheumatol Int."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e2030280","DOI":"10.1001\/jamanetworkopen.2020.30280","article-title":"Race\/ethnicity among children with COVID-19-associated multisystem inflammatory syndrome","volume":"3","author":"Lee","year":"2020","journal-title":"J Am Med Assoc Netw Open."},{"key":"B64","unstructured":"Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19)2020"},{"key":"B65","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1001\/jama.2020.13719","article-title":"Presence of genetic variants among young men with severe COVID-19","volume":"324","author":"van der Made","year":"2020","journal-title":"J Am Med Assoc."},{"key":"B66","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/s11427-020-1661-4","article-title":"Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China","volume":"63","author":"Hu","year":"2020","journal-title":"Sci China Life Sci."},{"key":"B67","unstructured":"The COVID Human Genetic Effort2021"},{"key":"B68","unstructured":"COVID-19 Host Genetics Initiative"},{"key":"B69","doi-asserted-by":"publisher","first-page":"abd4570","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"B70","doi-asserted-by":"publisher","first-page":"abd4585","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"B71","doi-asserted-by":"publisher","first-page":"14165","DOI":"10.18632\/oncotarget.3690","article-title":"CXCL16\/CXCR6 chemokine signaling mediates breast cancer progression by pERK1\/2-dependent mechanisms","volume":"6","author":"Xiao","year":"2015","journal-title":"Oncotarget."},{"key":"B72","unstructured":"MarttilaM\n            FauconA\n            VadgamaN\n            AndrewsS\n            WolfordB\n            VeerapenK\n          COVID-19 HGI2021"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1101\/2021.11.08.21265944","article-title":"Mapping the human genetic architecture of COVID-19: an update","volume":"2021","author":"Initiative","year":"2021","journal-title":"medRxiv"},{"key":"B74","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00424-003-1192-y","article-title":"The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction","volume":"447","author":"Hediger","year":"2004","journal-title":"Pflugers Arch."},{"key":"B75","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12931-017-0581-2","article-title":"Genome-wide association study of subclinical interstitial lung disease in MESA","volume":"18","author":"Manichaikul","year":"2017","journal-title":"Respir Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"S197","DOI":"10.1016\/S0925-4773(03)00116-3","article-title":"Foxp4: a novel member of the Foxp subfamily of winged-helix genes co-expressed with Foxp1 and Foxp2 in pulmonary and gut tissues","volume":"119","author":"Lu MM Li","year":"2002","journal-title":"Mech Dev."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1152\/physrev.00004.2016","article-title":"Idiopathic pulmonary fibrosis: a genetic disease that involves mucociliary dysfunction of the peripheral airways","volume":"96","author":"Evans","year":"2016","journal-title":"Physiol Rev."},{"key":"B78","doi-asserted-by":"publisher","first-page":"103629","DOI":"10.1016\/j.ebiom.2021.103629","article-title":"Host genetic factors determining COVID-19 susceptibility and severity","volume":"72","author":"Velavan","year":"2021","journal-title":"EBioMedicine."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1073\/pnas.1519657113","article-title":"Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses","volume":"113","author":"Li","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"B80","doi-asserted-by":"publisher","first-page":"pnas","DOI":"10.1073\/pnas.2026309118","article-title":"A genomic region associated with protection against severe COVID-19 is inherited from Neandertals","volume":"118","author":"Zeberg","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B81","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-020-03065-y","article-title":"Genetic mechanisms of critical illness in COVID-19","volume":"591","author":"Pairo-Castineira","year":"2021","journal-title":"Nature."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1101\/2021.03.10.21252820","article-title":"Mapping the human genetic architecture of COVID-19 by worldwide meta-analysis","volume":"2021","author":"Ganna","year":"2021","journal-title":"medRxiv"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1056\/NEJMoa2020283","article-title":"Genomewide association study of severe covid-19 with respiratory failure","volume":"383","author":"Ellinghaus","year":"2020","journal-title":"N Engl J Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"631148","DOI":"10.3389\/fmed.2020.631148","article-title":"ACE gene I\/D polymorphism and acute pulmonary embolism in COVID-19 pneumonia: a potential predisposing role","volume":"7","author":"Calabrese","year":"2020","journal-title":"Front Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"e2323","DOI":"10.1002\/rmv.2323","article-title":"Genetic polymorphisms of ACE1, ACE2, and TMPRSS2 associated with COVID-19 severity: a systematic review with meta-analysis","volume":"2022","author":"Saengsiwaritt","year":"2022","journal-title":"Rev Med Virol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e06133","DOI":"10.1016\/j.heliyon.2021.e06133","article-title":"ACE2 and FURIN variants are potential predictors of SARS-CoV-2 outcome: a time to implement precision medicine against COVID-19","volume":"7","author":"Al-Mulla","year":"2021","journal-title":"Heliyon."},{"key":"B87","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/iid3.358","article-title":"Association between HLA gene polymorphisms and mortality of COVID-19: an in silico analysis","volume":"8","author":"Tomita","year":"2020","journal-title":"Immun Inflamm Dis."},{"key":"B88","doi-asserted-by":"publisher","first-page":"641900","DOI":"10.3389\/fimmu.2021.641900","article-title":"Association of HLA class I genotypes with severity of coronavirus disease-19","volume":"12","author":"Shkurnikov","year":"2021","journal-title":"Front Immunol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"605688","DOI":"10.3389\/fimmu.2020.605688","article-title":"Human leukocyte antigen complex and other immunogenetic and clinical factors influence susceptibility or protection to SARS-CoV-2 infection and severity of the disease course. The Sardinian experience","volume":"11","author":"Littera","year":"2020","journal-title":"Front Immunol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"101099","DOI":"10.1016\/j.eclinm.2021.101099","article-title":"Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01","volume":"40","author":"Weiner","year":"2021","journal-title":"EClinicalMedicine."},{"key":"B91","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/TP.0000000000003507","article-title":"HLA and AB0 polymorphisms may influence SARS-CoV-2 infection and COVID-19 severity","volume":"105","author":"Amoroso","year":"2021","journal-title":"Transplantation."},{"key":"B92","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/tan.14047","article-title":"HLA allele frequencies and susceptibility to COVID-19 in a group of 99 Italian patients","volume":"96","author":"Novelli","year":"2020","journal-title":"HLA."},{"key":"B93","doi-asserted-by":"publisher","first-page":"6317","DOI":"10.1038\/s41467-020-19741-6","article-title":"Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission","volume":"11","author":"Peckham","year":"2020","journal-title":"Nat Commun."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.annonc.2020.04.479","article-title":"Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532)","volume":"31","author":"Montopoli","year":"2020","journal-title":"Ann Oncol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.annonc.2020.08.2096","article-title":"The potential influence of human Y-chromosome haplogroup on COVID-19 prevalence and mortality","volume":"31","author":"Delanghe","year":"2020","journal-title":"Ann Oncol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"100989","DOI":"10.1016\/j.mgene.2021.100989","article-title":"Interleukin-37 gene polymorphism and susceptibility to coronavirus disease 19 among Iraqi patients","volume":"31","author":"Ahmed","year":"2022","journal-title":"Meta Gene."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1177\/2047487320931305","article-title":"C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism","volume":"27","author":"Delanghe","year":"2020","journal-title":"Eur J Prev Cardiol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1016\/j.clnu.2017.10.024","article-title":"Vitamin D pathway gene polymorphisms influenced vitamin D level among pregnant women","volume":"37","author":"Shao","year":"2018","journal-title":"Clin Nutr"},{"key":"B99","unstructured":"NasirJ\n            WolfordB\n            VeerapenK\n          COVID-19 HGI Results for Data Freeze 4 (October 2020). Host Genetics Initiative2020"},{"key":"B100","unstructured":"COVID-19 Vaccine Tracker and Landscape2021"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1001\/jama.2021.3199","article-title":"SARS-CoV-2 vaccines","volume":"325","author":"Creech","year":"2021","journal-title":"J Am Med Assoc."},{"key":"B102","unstructured":"COVID-19 Vaccines: European Medicines Agency2021"},{"key":"B103","doi-asserted-by":"publisher","first-page":"687","DOI":"10.7326\/M21-0111","article-title":"SARS-CoV-2 vaccines: much accomplished, much to learn","volume":"174","author":"Connors","year":"2021","journal-title":"Ann Intern Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1101\/2020.12.09.20245175","article-title":"BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans","volume":"2020","author":"Sahin","year":"2020","journal-title":"medRxiv"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2 - preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"N Engl J Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1016\/S0140-6736(20)32466-1","article-title":"Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2\/3 trial","volume":"396","author":"Ramasamy","year":"2021","journal-title":"Lancet."},{"key":"B107","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1056\/NEJMoa2034201","article-title":"Interim results of a phase 1\u20132a trial of Ad26COV2S covid-19 vaccine","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med."},{"key":"B109","volume-title":"Infections Are Rising in Mongolia, Where Half the People Have Received the Sinopharm Vaccine","author":"Stevenson","year":"2021"},{"key":"B110","volume-title":"Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial","year":"2021"},{"key":"B111","unstructured":"HowardJ\n          Novavax Says Covid-19 Vaccine Shows 90.4% Overall Efficacy in US\/Mexico Phase 3 Trial2021"},{"key":"B112","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.cell.2020.09.040","article-title":"Why and how vaccines work","volume":"183","author":"Iwasaki","year":"2020","journal-title":"Cell."},{"key":"B113","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41565-020-00820-0","volume":"15","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1089\/vim.2017.0026","article-title":"Modes of action for mucosal vaccine adjuvants","volume":"30","author":"Aoshi","year":"2017","journal-title":"Viral Immunol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1101\/2020.12.14.20248176","article-title":"Genome-wide analysis in 756,646 individuals provides first genetic evidence that ACE2 expression influences COVID-19 risk and yields genetic risk scores predictive of severe disease","volume":"2021","author":"Horowitz","year":"2021","journal-title":"medRxiv"},{"key":"B116","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/rmv.430","article-title":"Measles virus receptors: SLAM and CD46","volume":"14","author":"Dhiman","year":"2004","journal-title":"Rev Med Virol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S1473-3099(20)30942-7","article-title":"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial","volume":"21","author":"Ella","year":"2021","journal-title":"Lancet Infect Dis."},{"key":"B118","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/21645515.2014.1004026","article-title":"Advances in aluminum hydroxide-based adjuvant research and its mechanism","volume":"11","author":"He","year":"2015","journal-title":"Hum Vaccin Immunother."},{"key":"B119","unstructured":"EganC\n            KnightS\n            BaillieK\n            HarrisonE\n            DochertyA\n            SempleC\n          ISARIC4C Consortium COVID-19 Clinical Information Network (CO-CIN)Hospitalised Vaccinated Patients During the Second Wave, Update April \u2018212021"},{"key":"B120","doi-asserted-by":"publisher","first-page":"n1127","DOI":"10.1136\/bmj.n1127","article-title":"Covid-19: most people admitted to hospital after vaccination were infected before immunity could develop, research shows","volume":"373","author":"Mahase","year":"2021","journal-title":"BMJ."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/S0140-6736(21)00624-3","article-title":"COVID-19 vaccines in high-risk ethnic groups","volume":"397","author":"D'Souza","year":"2021","journal-title":"Lancet."},{"key":"B122","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med."},{"key":"B123","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med."},{"key":"B124","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.cels.2020.11.010","article-title":"Predicted Cellular Immunity Population Coverage Gaps for SARS-CoV-2 subunit vaccines and their augmentation by compact peptide sets","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Syst"},{"key":"B125","unstructured":"COVID-19 Vaccines: Missing Race & Ethnicity Data \/ Single-Dose Effectiveness \/ J&J Recommendations.\n            AmyH\n          2021"},{"key":"B126","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/ane.13451","article-title":"SARS-CoV-2 vaccines are not free of neurological side effects","volume":"144","author":"Finsterer","year":"2021","journal-title":"Acta Neurol Scand."},{"key":"B127","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1056\/NEJMe2106315","article-title":"SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia","volume":"384","author":"Cines","year":"2021","journal-title":"N Engl J Med"},{"key":"B128","doi-asserted-by":"publisher","first-page":"100084","DOI":"10.1016\/j.xhgg.2021.100084","article-title":"HLA-A*03:01 is associated with increased risk of fever, chills, and stronger side effects from Pfizer-BioNTech COVID-19 vaccination","volume":"3","author":"Bolze","year":"2022","journal-title":"HGG Adv."},{"key":"B129","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3109\/08820139.2013.859156","article-title":"Combined immunodeficiency presenting with vaccine-associated paralytic poliomyelitis: a case report and narrative review of literature","volume":"43","author":"Shaghaghi","year":"2014","journal-title":"Immunol Invest."},{"key":"B130","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41576-020-00297-6","article-title":"Host genetics and infectious disease: new tools, insights and translational opportunities","volume":"22","author":"Kwok","year":"2021","journal-title":"Nat Rev Genet."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.jaci.2021.08.016","article-title":"Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity","volume":"148","author":"Delmonte","year":"2021","journal-title":"J Allergy Clin Immunol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"815404","DOI":"10.3389\/fimmu.2021.815404","article-title":"The immune response to SARS-CoV-2 vaccination: insights learned from adult patients with common variable immune deficiency","volume":"12","author":"Quinti","year":"2022","journal-title":"Front Immunol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.802312\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T06:46:23Z","timestamp":1646981183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.802312\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,11]]},"references-count":132,"alternative-id":["10.3389\/fmed.2022.802312"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.802312","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,11]]},"article-number":"802312"}}